Tactile Medical to Present at the Guggenheim 2021 MedTech Disruptors Summit
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced its participation in the Guggenheim 2021 MedTech Disruptors Summit, taking place virtually on August 9-10, 2021. The management will engage in a fireside chat on August 9 at 3:00 p.m. Eastern Time. Tactile Medical specializes in at-home therapy devices for chronic conditions like lymphedema and chronic venous insufficiency. Their mission is to enhance patients' quality of life through advanced pneumatic compression devices and comprehensive care services, ensuring effective at-home treatment for thousands annually.
Details
News Market Reaction – TCMD
The recorded move for TCMD in the trading session of this news was -2.22%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim 2021 MedTech Disruptors Summit, which is being held virtually from August 9th-10th. Management will participate in a fireside chat on Monday, August 9th at 3:00 p.m. Eastern Time.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.